Related Experiment Video
Updated: Mar 22, 2026

10:26
In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
13.3K
Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition
Srimoyee Ghosh1, Alexander Taylor1, Melissa Chin1
1From the Constellation Pharmaceuticals, Inc., Massachusetts 02142 and.
The Journal of Biological Chemistry
|April 9, 2016
Summary
Researchers developed small molecule inhibitors targeting CREBBP/EP300 bromodomains. These inhibitors are crucial for understanding regulatory T cell biology and offer a new strategy for cancer immunotherapy by blocking immune evasion.
Area of Science:
- Epigenetics and Gene Regulation
- Chemical Biology
- Immunology
Background:
- Histone modifications are key to gene expression and epigenetic control.
- Bromodomains recognize acetylated histones, linking chromatin to transcription.
- Targeting bromodomain interactions offers insight into biological processes.
Purpose of the Study:
- To discover and characterize small molecule inhibitors for CREBBP/EP300 bromodomains.
- To investigate the role of CREBBP/EP300 bromodomains in regulatory T cell biology.
- To explore the potential of CREBBP/EP300 bromodomain inhibition in cancer immunotherapy.
Main Methods:
- Discovery and characterization of small molecule inhibitors.
- In vitro and cellular assays to assess inhibitor potency and selectivity.
- Investigation of CREBBP/EP300 bromodomain function in regulatory T cells.
Main Results:
- Identification of potent and selective small molecule inhibitors for CREBBP/EP300 bromodomains.
- Demonstration of a critical role for CREBBP/EP300 bromodomains in regulatory T cell biology.
- Evidence supporting CREBBP/EP300 bromodomain inhibition as a cancer immunotherapy approach.
Conclusions:
- CREBBP/EP300 bromodomain inhibitors are valuable tools for biological research.
- Targeting CREBBP/EP300 bromodomains impacts regulatory T cell function.
- Inhibition of CREBBP/EP300 bromodomains presents a novel strategy for cancer immunotherapy.
Related Concept Videos
Negative Regulator Molecules
38.8K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
Master Transcription Regulators
8.0K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K
Co-activators and Co-repressors
8.8K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.8K
Receptor Downregulation in MVBs
3.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
3.0K
TGF - β Signaling Pathway
10.9K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K

